Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A case of true acute eosinophilic leukemia arising from myelodysplastic syndrome.

Journal of hematopathology·2026

Same author

All-Oral Treatment of Newly Diagnosed Acute Myeloid Leukemia.

The New England journal of medicine·2026

Same author

CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS).

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS Lymphoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

CGE26-139: Genomic Signatures of CNS and Systemic Relapse in Diffuse Large B-Cell Lymphoma (DLBCL) Patients Profiled With Next Generation Sequencing (NGS).

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

YIA26-002: Automated Segmentation and Radiogenomic Analysis of Primary CNS Lymphoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Search research articles

Related Experiment Video

Updated: Mar 1, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

How I treat CNS lymphomas.

James L Rubenstein¹, Neel K Gupta, Gabriel N Mannis

¹Division of Hematology/Oncology, Helen Diller Comprehensive Cancer Center.

|August 22, 2013

Summary

Advances in understanding central nervous system (CNS) lymphoma pathogenesis and treatment offer hope for long-term survival. Multidisciplinary care is crucial for diagnosing and managing these complex CNS lymphomas.

Area of Science:

Neuro-oncology
Hematology
Molecular Biology

Background:

Primary and secondary central nervous system (CNS) lymphoma present complex diagnostic, prognostic, and therapeutic challenges.
Recent advancements have improved understanding of CNS lymphoma molecular properties and microenvironment.
Novel treatment strategies have evolved, shifting outlooks from uniformly dismal to potential long-term survival.

Purpose of the Study:

To provide an overview of current knowledge on CNS lymphoma pathogenesis.
To highlight promising strategies for diagnosis, staging, and therapeutic management.
To emphasize the evolving principles of management for CNS lymphoma patients.

Main Methods:

Review of recent scientific literature on CNS lymphoma.

More Related Videos

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Experiment Videos

Last Updated: Mar 1, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Analysis of molecular properties and microenvironment of CNS lymphomas.

Evaluation of novel treatment strategies and multidisciplinary care approaches.

Main Results:

Significant progress in elucidating molecular pathogenesis of CNS lymphomas.
Evolution of novel treatment strategies leading to improved survival rates.
Recognition of the need for multidisciplinary teams in managing CNS lymphoma.

Conclusions:

Long-term survival and potential cure are now achievable for a significant fraction of CNS lymphoma patients.
Effective management requires a multidisciplinary team with diverse expertise.
Continued research into pathogenesis and treatment strategies is essential for further improving outcomes.